Individuals with abnormal glucose and lipid metabolism
Conditions
Interventions
Low-dose group:Containing 180mg oat hydrolyzed protein per tablet
Low-dose group:Containing 360mg oat hydrolyzed protein per tablet
Sponsors
Guangzhou Eighth People's Hospital Affiliated to Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Age: 18 - 50 years old (inclusive of boundary values), gender not restricted; 2. 24.0 kgm^2 <= BMI <= 28.0 kg/m^2; 3. Fasting blood glucose level is between 5.6 - 7.0 mmol/L; 4. Within the past 1 month, weight change <= 3 kg; 5. Can read Chinese, can accurately understand the trial process, voluntarily participate in the trial and sign the informed consent form for the trial research; 6. Can cooperate with and participate in the follow-up time of the trial research, and promptly report one's own health condition or any changes in food, adverse reaction symptoms, be able to comply with the research requirements and time arrangements.
Exclusion criteria
Exclusion criteria: 1. Including diseases of important organs such as the heart, liver, lungs, kidneys, etc., blood diseases, tumor diseases, etc.; 2. Individuals with severe mental disorders, who cannot control their behaviors and cannot cooperate with the study; 3. Those who have taken items related to the study function (drugs, health supplements, hormones, etc.) within the last 3 months, which may affect the judgment of the results; 4. History of digestive system diseases, such as chronic gastritis, inflammatory bowel disease, irritable bowel syndrome, peptic ulcer, etc.; or those who have a history of gastrointestinal surgery; 5. Individuals with allergic constitution or who may be allergic to the components of the test product; 6. Pregnant women, those planning to get pregnant or breastfeeding women; 7. Those who have participated in or are currently participating in other clinical studies within the last 3 months; 8. Individuals judged by the researcher to be unsuitable for this trial or who are prone to drop out.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body composition: height, weight, BMI, waist circumference;Glucagon-like peptide-1 (GLP-1);Plasma peptide YY (PYY) and ghrelin levels;Insulin resistance index;Lipid profile four items;VAS scale assessment of satiety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs;General condition (including mental status, sleep, diet, bowel and bladder function, blood pressure, etc.); | — |
Countries
China
Contacts
Public ContactHan Yajuan
Guangzhou Eighth People's Hospital Affiliated to Guangzhou Medical University
Outcome results
None listed